Novo Nordisk makes both Tresiba and Ozempic (semaglutide)
Personalized medicine approaches The future of GLP-1 therapy in Hashimoto's likely involves more personalized approaches
For those of us keeping an eye on our glucose, Retatrutide appears to assist the body in maintaining more stable levels, which can lead to more consistent energy throughout the day and avoid those uncomfortable energy crashes
The researchers studied the frequency of alopecia in adults with type 2 diabetes taking GLP-1 drugs, compared with those taking SGLT-2 inhibitors or DPP-4 inhibitors
At the 12 mg dose, systolic blood pressure dropped by 14.0 mmHg, with reductions in non-HDL cholesterol, triglycerides, and high-sensitivity CRP (a marker of inflammation)
These medications significantly reduce appetite and promote early satiety, naturally lowering calorie intake